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The intestinal epithelium harbors large populations
of activated and memory lymphocytes, yet these
cells do not cause tissue damage in the steady state.
We investigated how intestinal T cell effector differ-
entiation is regulated upon migration to the intestinal
epithelium. Using gene loss- and gain-of-function
strategies, as well as reporter approaches, we
showed that cooperation between the transcription
factors T-bet and Runx3 resulted in suppression of
conventional CD4+ T helper functions and induction
of an intraepithelial lymphocyte (IEL) program that
included expression of IEL markers such as CD8aa
homodimers. Interferon-g sensing and T-bet expres-
sion by CD4+ T cells were both required for this
program, which was distinct from conventional T
helper differentiation but shared by other IEL popula-
tions, including TCRab+CD8aa+ IELs. We conclude
that the gut environment provides cues for IEL matu-
ration through the interplay between T-bet and
Runx3, allowing tissue-specific adaptation of mature
T lymphocytes.
INTRODUCTION
Interposed between intestinal epithelial cells, intraepithelial lym-
phocytes (IELs) constitute the most abundant T cell population
in the body (Meresse et al., 2012). Developing T cells differen-
tiate into IELs from precommitted thymic precursors (Gangad-
haran et al., 2006; Guy-Grand et al., 2013). Additionally, mature
T cells can acquire IEL-like characteristics upon peripheral acti-
vation under appropriate conditions (Denning et al., 2007; Guy-
Grand et al., 1991; Huang et al., 2011; Mucida et al., 2013; Reis
et al., 2013). Thymic (TCRgd+CD8aa+ and TCRab+CD8aa+)
and peripherally-converted (TCRab+ CD8ab+CD8aa+ and CD4+
CD8aa+) IELs are commonly described as ‘‘natural’’ and
‘‘induced’’ IELs, respectively (Cheroutre et al., 2011). IELs are
characterized by high expression of activation markers such
as CD69; gut-homing integrins, including CD103 (aEb7); NK-
like receptors such as 2B4; cytotoxic (CTL)-related genes
such as granzyme B and Runx3; and anti-inflammatory or inhib-
itory receptors like LAG-3; which define these cells as ‘‘acti-
vated yet resting’’ (Denning et al., 2007; Pobezinsky et al.,244 Immunity 41, 244–256, August 21, 2014 ª2014 Elsevier Inc.2012). Irrespective of their nature, tightly regulated control of
IEL function is crucial for the maintenance of the epithelial cell
barrier and gut physiological inflammation (Tang et al., 2009).
Inappropriate activation of the CTL capacity of IELs can induce
chronic inflammatory disorders such as celiac disease (Tang
et al., 2009).
Another common characteristic of IELs is the surface expres-
sion of CD8aa homodimers, which can bind both to classical
MHC-I and to epithelial cell-associated non-classical MHC-I
molecules, such as mouse thymic leukemia antigen (TL), pre-
sumably working as TCR ‘‘corepressors’’ (Cheroutre and Lam-
bolez, 2008; Cheroutre et al., 2011; Gangadharan et al., 2006;
Guy-Grand et al., 1991; Guy-Grand et al., 2013). In addition, pe-
ripheral mature CD4+ T cells can acquire CD8aa expression
upon migration to the intestine (Das et al., 2003; Mucida et al.,
2013; Reis et al., 2013). This process is linked to acquisition of
IEL characteristics, expression of the long-form (encoded by
its distal promoter) of the transcription factor Runx3 and loss
of expression of the key CD4+ T cell differentiation transcription
factor ThPOK (also known as Zbtb7b and cKrox), which results in
the loss of CD4+ T helper function (Mucida et al., 2013; Pobezin-
sky et al., 2012; Reis et al., 2013). However, despite the role of
this pathway in different pathophysiological conditions (Mucida
et al., 2013; Reis et al., 2013), the contributions of different
signals and transcription factors to the induction of CD4+ IEL dif-
ferentiation and suppression of T helper function are not yet
understood.
In this study, we investigated the molecular mechanisms by
which the intestinal environment mediates suppression of
T helper (Th) programs and induces an IEL phenotype in peri-
pheral CD4+ T cells. We discovered that upregulation of the
transcription factor T-bet and interferon-g (IFN-g) or inter-
leukin-27 (IL-27) signaling were required for IEL differentiation
both in vitro and in vivo. The molecular requirements for the
induction of this phenotype were distinct from those required
for classical Th1 cell differentiation, typically associated with
T-bet expression and IFN-g production, and required syner-
gistic effects of the transcription factors T-bet and Runx3.
T-bet was found to bind Zbtb7b and Runx3 in differentiating
IELs, assisting Runx3-dependent upregulation of genes asso-
ciated with IELs, whereas T-bet-dependent suppression of
T helper programs was largely Runx3 independent. We con-
clude that the gut environment provides cues for terminal
IEL differentiation through the interplay between cytokine-
regulated T-bet and Runx3, allowing tissue-specific adapta-
tion and reprogramming of mature lymphocytes in the chroni-
cally stimulated mucosa.
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T-bet Upregulation Is Linked to IEL Differentiation
Loss of ThPOK and acquisition of Runx3 by intestinal CD4+
T cells results in reduced T helper-associated gene expression,
including that of Th2, Th17, and Treg cells. Moreover, CD4+
T cells undergoing this transition acquire cytotoxic and IEL
gene-expression patterns, including high levels of CD8aa,
CD103 (aEb7), 2B4 (CD244), and granzyme B expression (Mu-
cida et al., 2013; Reis et al., 2013). This pattern, hereafter
referred to as ‘‘CD4-IEL differentiation,’’ resembles the pattern
of effects on peripheral CD4+ and CD8+ T cells known to be
mediated by T-bet, such as suppression of Th2, Th17, and
Treg cell differentiation and enhancement of Th1 and CD8+
effector T cell differentiation (Cruz-Guilloty et al., 2009; Djuretic
et al., 2007; Koch et al., 2009; Lazarevic et al., 2011; Zhu et al.,
2012). Consistent with a potential link between T-bet and IEL dif-
ferentiation, analysis of Tbx21 (encoding T-bet) mRNA expres-
sion in ex vivo sorted small intestine IELs from naive wild-type
(WT) mice revealed that all IEL populations expressed increased
amounts of Tbx21 when compared to peripheral T cells (Fig-
ure 1A). Corresponding to this increased expression in cells
that have undergone IEL differentiation, mRNA analysis of sorted
small intestine CD4+ IELs from naive Zbtb7b-GFP knockin re-
porter mice indicated that Tbx21 was upregulated in ThPOKlo
cells (Figure 1B). Protein expression analysis further confirmed
that expression of T-bet by CD4+ IELs closely mirrored the
expression pattern of long-form Runx3 (Reis et al., 2013) and
the expression pattern of other IEL-associated proteins, such
as 2B4 and CD103, which were upregulated in CD4+CD8aa+
IELs (Figure 1C).
To evaluate whether T-bet upregulation correlated with
induced CD4-IEL differentiation, we initially used an in vitro
approach. We cultured naive, OVA-specific OTII CD4+ T cells
with WT splenic dendritic cells (DCs) and OVA peptide in the
presence of exogenous recombinant cytokines. This system
allowed us to study the effects of a particular cytokine milieu
on IEL differentiation in the context of a set T cell receptor
(TCR) specificity. We compared conditions known to induce
T-bet expression in CD4+ T cells (IL-12 plus anti-IL-4, Th1 cell
conditions) with conditions associated with CD4+CD8aa+ differ-
entiation (TGF-b and retinoic acid [RA]). We previously reported
that the latter combination concomitantly induces a Foxp3+
(T-betlo) Treg cell population (Mucida et al., 2007) and a reduced
CD4+CD8aa+ IEL-like population that exhibits increased Tbx21
mRNA expression compared to the Foxp3+ compartment (Reis
et al., 2013). While Th1 cell conditions induced robust T-bet
expression and IFN-g production, this was not observed in
TGF-b and RA-treated cells (Figure 1D). Contrary to TGF-b and
RA alone, addition of direct T-bet inducers abundant in the intes-
tinal milieu, specifically IFN-g and IL-27, also resulted in high
T-bet and IFN-g expression by OTII cells and, when added in
combination with TGF-b and RA, led to intermediate to high
T-bet and IFN-g production (Figure 1D). Addition of IFN-g or
IL-27 also suppressed TGF-b and RA-mediated Foxp3 induc-
tion, consistent with the reported negative effect of T-bet on
Treg cell induction (Figure 1E). In contrast, these T-bet-inducing
cytokines boosted expression of the IEL-associated markers
CD103 and CD8aa when added to the TGF-b and RA regimen(Figure 1F). Similar to ex vivo isolated IELs (Figure 1C), induction
of CD8aa expression by these conditions wasmostly confined to
the CD103hi population (Figure 1F).
To better evaluate transcription-factor dynamics in different
conditions and confirm this correlation with the CD4+ IEL
signature, we used OTII cells from mice on a Zbtb7b-GFP or a
Runx3-YFP background. We found that TGF-b and RA plus
IFN-g suppressed ThPOK expression and concurrently induced
Runx3, whereas Th1 cell-polarizing conditions induced Runx3
upregulation without resulting in ThPOK loss (Figure 1G). In
contrast, the combination of TGF-b and RA plus IFN-g resulted
in stronger suppression of ThPOK than TGF-b and RA alone (Fig-
ures 1G and 1H). Less significant results were obtained with
IL-15, which has been also reported to induce T-bet (Intlekofer
et al., 2005). When added in combination with TGF-b and RA,
IL-15 slightly enhanced CD4+CD8aa+ induction, although we
did not observe any additional ThPOK downmodulation (see Fig-
ure S1 available online). Similar to freshly isolated CD4+ IELs,
CD8aa and CD103 expression was mostly found in the ThPOKlo
population (Figure 1H). To confirm that qualitatively distinct dif-
ferentiation programs were induced in these cells, we examined
the gene-expression profile from in vitro-induced Th1 cells
(ThPOKhi CD8aa) and in vitro-induced CD4+ IELs (ThPOKlo
CD8aa+). While sorted cells treated with IL-12 plus anti-IL-4 ex-
pressed hallmark Th1 cell genes, such as Il12rb1, Ccr5, Irf4, and
Csf2r, TGF-b+RA+IFN-g-treated cells expressed IEL-associated
genes, such as Crtam and Runx3, but similar amounts of Tbx21
and Gzmb to Th1 cells (Figure S1). These observations demon-
strate that an IEL-inducing cytokine milieu leads to concomitant
upregulation of T-bet and Runx3, suggesting a potential role for
this pathway in IEL maturation or differentiation.
T-bet Regulates IEL Development
We next examined the requirements for T-bet in the CD4-IEL dif-
ferentiation process. First, we compared CD4+ T cells from WT
OTII mice to those of OTII mice crossed with Tbx21–/– mice
(OTII [DTbx21]) for their IEL differentiation capacity. Because
we have previously shown that Runx3 is required for this process
in vivo (Reis et al., 2013), we compared these cells to CD4+
T cells isolated from conditional Runx3-deficient mice (OTII
[DRunx3]) for CD4-IEL differentiation. We found that both OTII
(DRunx3) and OTII (DTbx21) cells failed to upregulate CD8aa
and CD103 expression upon TGF-b+RA+IFN-g treatment (Fig-
ures 2A and 2B). In similar experiments, we found that lack of
either T-bet or Runx3 in polyclonal CD4+ T cells also impairs
downmodulation of ThPOK upon culture in CD4-IEL-differenti-
ating conditions (Figure 2C).
To directly assess the role of T-bet in IEL maturation in vivo,
we isolated intestinal cells from naive WT or Tbx21–/– mice.
We found that in Tbx21–/– animals, all CD8aa-expressing IEL
populations were reduced: TCRgd+CD8aa+, TCRab+CD8aa+,
TCRab+CD8b+CD8aa+, and TCRab+CD4+CD8aa+ (Figures
2D–2I). The ratio of TCRgd+ to TCRab+ among CD45+ cells
was also significantly reduced in mice lacking T-bet (Fig-
ure 2E). Another hallmark of IELs, CD103, was found to be
reduced in the TCRab+ CD4+ IEL population, mostly due to
a drastic reduction in the (CD103hi) CD4+CD8aa+ population
in the Tbx21–/– mice (Figures 2G and 2H). This reduced fre-
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Role of T-bet in IEL Maturationolder animals, indicating that T-bet requirement is likely not
restricted to early waves of T cell egress from the thymus
(Figure 2I).
The reduced frequency of CD4+CD8aa+ IELs in Tbx21–/–
mice prompted us to investigate whether T-bet plays a role
in the modulation of ThPOK expression by intestinal CD4+
T cells. To address this question, we interbred Tbx21–/– mice
with Zbtb7b-GFP reporter mice. Analysis of naive Zbtb7b-GFP
(Tbx21–/–) mice indicated that both CD8aa induction and ThPOK
downmodulation were significantly impaired in the absence of
T-bet (Figure 2J). Conversely, IL-17 production by CD4+ T cells
from the IEL compartment was enhanced in mice without
T-bet, which suggests that T-bet mediates suppression of the
Th17 program and Th17-associated genes in differentiating
CD4+ IELs (Figure 2K). These data indicate that T-bet is essen-
tial for both ‘‘natural’’ and ‘‘induced’’ IEL development and
maturation.
Cell-Intrinsic Effects of T-bet on CD4-IEL Maturation
Tbx21–/– mice display immune-related defects associated with
several immune cell populations, including NK cells, T helper
cells, and CD8+ T cells (Szabo et al., 2002). To exclude cell-
extrinsic effects of T-bet deficiency and evaluate CD4-IEL dif-
ferentiation in an in vivo inflammatory setting, we used the
T cell transfer model of colitis (Powrie et al., 1994). Sorted naive
CD4+ T cells from Zbtb7b-GFP or Zbtb7b-GFP (Tbx21–/–) mice
were adoptively transferred into Rag1–/– hosts. Similar to what
had been previously described, Tbx21–/– donor naive T cells
did not induce significant weight loss and colitis, likely due
to impaired differentiation of Th1 or absence of another
pathogenic CD4+ T cell population (Neurath et al., 2002; data
not shown). In line with our ex vivo and in vitro data with
Tbx21–/– mice, we found reduced loss of ThPOK and reduced
CD8aa induction by donor Tbx21–/– CD4+ T cells (Figures 3A
and 3B).
In naive WT animals, IL-17 production is restricted to ThPOKhi
or Runx3lo intestinal CD4+ T cells (Reis et al., 2013). Consistent
with a role for T-bet in suppressing IL-17 production by CD4-
IEL, we found that adoptive transfer of naive CD4+ T cells from
WT or Tbx21–/– mice into Rag1–/– hosts resulted in increased
frequency of IL-17-producing CD4+ T cells, particularly in the in-
testinal tissues of Tbx21–/– T cell hosts, whereas IFN-g produc-
tion was not significantly altered (Figures 3C–3F). This is in line
with previous studies describing T-bet-independent develop-
ment of IFN-g-producing CD4+ T cells (Djuretic et al., 2007).
Finally, similar to Th17 cell differentiation, Treg cell and CD4-
IEL differentiation from mature naive CD4+ T cells also occurs
in a mutually exclusive fashion (Mucida et al., 2013). Consistent
with this pattern, Foxp3 induction was enhanced in several tis-
sues from Tbx21-deficient CD4+ T cell hosts, suggesting a roleFigure 1. T-bet Upregulation Is Linked to IEL Differentiation
(A) Expression of Tbx21 by sorted small intestine IEL populations, TCRab+CD4+, T
(CD4–, CD8b–), and naive splenic CD4+ T cells from WT mice.
(B) Expression Tbx21 by sorted small intestine IEL populations, TCRb+CD4+CD8
(C) CD8a, T-bet, 2B4, and CD103 expression by TCRb+CD4+CD8b– small intesti
(D–H) In vitro CD4+CD8aa+ IEL induction. Sorted, naive Va2+CD4+ T cells isolate
were cocultured with DCs, OVA peptide, and indicated cytokines. (D) T-bet and IF
Histograms of ThPOK (left) or Runx3 (right) expression by OTII cells from diffe
CD4+CD8b– OTII cells. (B) Error bars represent SEM of triplicates. All plots are refor T-bet in the suppression of peripheral Treg differentiation
(Figure 3G). Taken together, these data support a cell-intrinsic
effect of T-bet on IEL programming.
Runx3 and T-bet Play Both Synergistic and
Complementary Roles in Functional Differentiation
of Intestinal T Cells
Transfer of primary CD4+ T cells from Cd4(DRunx3) mice into
Rag1–/– hosts results in accelerated colitis and reduced loss
of ThPOK or upregulation of CD8aa by these transferred CD4+
T cells (Reis et al., 2013). Furthermore, the congruence
we observed in T-bet or Runx3-deficient CD4+ T cells in vitro
suggests either interdependence or a hierarchy of these tran-
scription factors in the IEL maturation process. To dissect the
individual Runx3 and T-bet roles in IEL programming in vivo,
we first overexpressed T-bet with Tbx21-encoding retrovirus
(IRES-Thy1.1) in primary CD4+ T cells isolated from WT and
Cd4(DRunx3) mice, both on Zbtb7b-GFP reporter backgrounds.
CD4+ T cells were sorted based on Thy1.1 and GFP expression
and adoptively transferred into Rag1–/– hosts. Supporting a role
for T-bet in IEL differentiation, overexpression of Tbx21 resulted
in enhanced CD8aa expression, CD103 induction, and ThPOK
loss by WT Tbx21, when compared to WT (mock)-transferred
cells (Figures 4A and 4B). However, in the absence of Runx3,
these effects were abrogated, implying a nonredundant role for
Runx3 in IEL programming (Figures 4A and 4B). Additionally,
about 50% of ThPOKlo cells in the Cd4(DRunx3)(Tbx21) re-
cipients did not express CD103, which indicates incomplete
CD4-IEL programming even in a population that has already
undergone ThPOK loss (Figure 4B).
Incontrast to IELdifferentiation, T-bet-mediatedsuppressionof
Th17differentiationappeared tobeRunx3-independent, because
Tbx21 overexpression resulted in reduced levels of RORgt
expression by CD4+ IELs even in transduced Cd4(DRunx3) cells
(Figure 4C). Similarly, we found that T-bet inhibited Foxp3 expres-
sion whether or not Runx3 was present (Figure 4D). These results
indicate that T-bet and Runx3 have complementary roles in
thedownregulationof ThPOKand the inductionof the IELdifferen-
tiation program. This differentiation program is distinct from the T-
bet-mediated suppressionof Th17 and Treg differentiation,which
was found to be independent of Runx3.
To further address whether the T-bet-Runx3 interplay is
involved in the suppression of the CD4+ T helper program, we
performed a rescue experiment in primary CD4+ T cells from
Tbx21–/– mice and studied Th17 cell differentiation in vitro. Over-
expression of T-bet by transduction with Tbx21-encoding retro-
virus significantly suppressed IL-17 expression and allowed
IFN-g production by Tbx21–/– CD4+ T cells (Figure 4E). Consis-
tent with previous reports (Djuretic et al., 2007; Wang et al.,
2014), overexpression of Runx3 by infecting Tbx21–/– CD4+CRab+CD8aa+ (CD4–, CD8b–), TCRab+CD8b+CD8aa+ (CD4–), TCRgd+CD8aa+
b– ThPOKlo and ThPOKhi from naive Zbtb7b -GFP reporter mice.
ne IELs of naive WT mice.
d from WT reporter OTII mice (OTII Zbtb7b -GFP) (D–G) or OTII Runx3-YFP (G)
N-g, (E) Foxp3, and (F) CD8a and CD103 expression by cultured OTII cells. (G)
rent culture conditions. (H) CD103, CD8a, and ThPOK expression by gated
presentative of at least three independent experiments.





Figure 2. T-bet Regulates IEL Development
Sorted naive Va2+CD4+ T cells isolated from WT (OTII), Tbx21–/– (OTII[DTbx21]) or Runx3 conditional knockout (OTII[DRunx3]) mice were cocultured with DCs,
OVA peptide, and TGF-b+RA+IFN-g (A and B). (A) CD8a (contour plot) and (B) CD103 (histogram) expression by gated CD4+CD8b–T cells.
(C) Sorted naive polyclonal CD4+ T cells isolated fromWT,DTbx21 orCd4(DRunx3)Zbtb7b -GFP reporter micewere culturedwith plate-bound a-CD3 and soluble
a-CD28 in the presence of TGF-b+RA+IFN-g. Histogram of ThPOK expression by CD4+CD8b–T cells is shown.
(D–I) Ex vivo analysis of small intestinal IELs from 10- to 14-week-old (D–H) or 25- to 30-week-old (I) WT and Tbx21–/– mice. (D and I) TL-tetramer (CD8aa) and
CD8b expression by gated TCRab+CD4– IEL. (E) Ratio TCRgd+ to TCRab+ among CD45+ cells. (F) CD8aa quantification in natural IELs TCRgd+ (left) and
TCRab+CD8b–CD4– (right) T cells right. (G) CD8a andCD103 expression by TCRab+CD4+CD8b– IELs. (H) CD8aa quantification in induced IELs TCRab+CD4+ (left)
and TCRab+CD8b+ (right).
(J and K) Ex vivo analysis of small intestine IELs from 10- to 14-week-oldWT and Tbx21–/– Zbtb7b -GFP reporter mice. (J) ThPOK andCD103 expression by gated
TCRab+CD4+CD8b– cells; (K) IL-17 and CD8a expression by gated TCRab+CD4+CD8b– cells, stimulated with PMA and ionomycin. Plots are representative of at
least three independent experiments. Statistical significance analyzed by Student’s t test of pooled experiments. Error bars represent SEM. *p < 0.05; **p < 0.01;
***p < 0.001.
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Role of T-bet in IEL MaturationT cells with retrovirus encoding the long-form of Runx3 led to an
increased frequency of IFN-g and IFN-g-IL-17 double-producing
CD4+ T cells but had very little effect on IL-17 single-producing
cells (Figure 4E). Altogether, these data establish a role for T-
bet in the suppression of Th17 and Treg cell induction in the
context of IEL differentiation.248 Immunity 41, 244–256, August 21, 2014 ª2014 Elsevier Inc.Hierarchical Roles for Runx3 and T-bet in IEL
Differentiation
To investigate whether Runx3 could compensate for IEL-differ-
entiation defects observed in T-bet-deficient cells, we performed
rescue experiments with Tbx21–/– CD4+ T cells stimulated under








Figure 3. Cell-Intrinsic Effects of T-bet on CD4-IEL Maturation
(A–G) Sorted naive CD4+GFPhi T cells fromWT and Tbx21–/– Zbtb7b -GFP reporter mice were adoptively transferred to Rag1–/– recipient mice and analyzed 40 to
50 days later. (A) CD8a and CD103 expression, (B) ThPOK loss and CD8aa expression by gated TCRb+CD4+CD8b– small intestine IELs of recipient mice. (C–F)
Analysis of spleen, mesenteric lymph node (mLN), and large intestine IEL and LPL cells from recipient mice after PMA and ionomycin stimulation. (C) Plots for IL-
17 and IFN-g expression. (D–G) Frequency of (D) IL-17 single producer (SP), (E) IL-17-IFN-g double producer (DP), (F) IFN-g single producer, and (G) Foxp3
positive TCRb+CD4+CD8b– cells from two pooled independent experiments. Error bars represent SEM. *p < 0.05; **p < 0.01. Plots are representative of three
independent experiments.
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Role of T-bet in IEL Maturationinduce CD103 expression directly via Runx3 (Shi and Stavnezer,
1998), the absence of TGF-b-induced CD103 expression in
Tbx21–/– cells (Figure 2B) indicated that T-bet plays a role in
Runx3-dependent CD103 upregulation. Consistently, overex-
pression of Runx3 in Tbx21–/– CD4+ T cells efficiently rescued
CD103 expression to the same level of WT(Runx3) cells (Fig-
ure 5A). Although Runx3 was essential for in vitro IEL differentia-
tion, Runx1 overexpression was also able to rescue CD103
expression in Tbx21–/– CD4+ T cells (Figure 5A). To directly
address the role of T-bet in Runx3 expression in vivo, we crossed
Runx3-YFP knockin reporter mice with Tbx21–/– mice. We
observed that IEL populations isolated from Tbx21–/– mice (red
histograms) express lower amounts of Runx3 when compared
to WT control (blue histograms) IELs (Figure 5B). These results
were confirmed by quantitative PCR (qPCR) performed in sorted
IEL populations, which showed drastically reduced levels of
Runx3 mRNA expression by Tbx21–/– IELs when compared to
WT controls (Figure 5C).
We next asked whether T-bet directly binds to the Runx3
locus, possibly regulating its expression. The 39 kb and the
17 kb Runx3 regulatory regions were previously reported to
contain a T-bet binding motif (Nakayamada et al., 2011). There-
fore, we analyzed the binding of T-bet to these regions by chro-matin immunoprecipitation (ChIP) in naive CD4+ and CD8+
T cells. We used T-bet binding to the Up1 locus, as well as
ChIP with Tbx21–/– cells as negative controls and T-bet binding
to the Ifng locus as positive control for the reactions. We found
that T-bet binds to both 39 kb and 17 kb regions of Runx3 in
CD4+ and CD8+ T cells, although T-bet binding was increased
in CD8+ T cells when compared to CD4+ T cells particularly in
the 17 kb region (Figure 5D). We also observed T-bet bind-
ing to Runx3 39 kb and 17 kb regulatory regions of
in vitro differentiated CD4+CD8aa IELs or Th1 cells (Figure 5F).
These data provide a possible molecular mechanism behind
the reduced CD103 and Runx3 expression observed in
Tbx21–/– IELs, supporting a sequence of events where the bind-
ing of T-bet to Runx3 regulatory elements promotes Runx3
expression.
In addition to the modulation of Runx3 expression, our data
also suggested T-bet-mediated effects on ThPOK downmodu-
lation in developing CD4-IELs. We thus analyzed whether T-bet
could also bind to the Zbtb7b regulatory binding sites 1 and 2
(RBS 1 and 2), known to silence Zbtb7b transcription upon
Runx3 binding (Setoguchi et al., 2008). We found that in WT
cells, T-bet binds to both RBS 1 and 2 of Zbtb7b in CD4+,
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Role of T-bet in IEL Maturationline with reports showing protein cooperation between T-bet
and Runx3 for CD8+ CTL differentiation (Cruz-Guilloty et al.,
2009), the enhanced T-bet binding to Zbtb7b RBS in CD8+
T cells required Runx3 protein expression, because it was
abrogated in CD8+ T cells isolated from Cd4(DRunx3) mice
(Figure 5E). The above data suggest that reduced ThPOK and
increased Runx3 expression are permissive for T-bet binding
to Zbtb7b regulatory elements. Consistent with this hypothesis,
we observed strong T-bet binding to RBS1 and 2 in CD4-IEL,
but not in Th1 cells (Figure 5G). Altogether, the above data
supports a Runx3-dependent, T-bet-mediated repression of
Zbtb7b expression.
Retinoic Acid and T-bet-Inducing Cytokines Play
Specific Roles in IEL Differentiation
Finally, we addressed the contribution and potentially differential
effects of upstream T-bet-inducing signals involved in IEL differ-
entiation. The T-bet inducing cytokine IL-15 and its receptor
CD122 (IL-2Rb or IL-15Rb) have been shown to regulate crucial
steps of terminal IEL development (Gangadharan et al., 2006;
Pobezinsky et al., 2012; Suzuki et al., 1997). Because additional
T-bet-inducing cytokines, IFN-g and IL-27, were able to induce
an IEL phenotype in vitro and because these cytokines are
expressed in both healthy and inflamed intestine (Troy et al.,
2009), we asked whether IFN-g and IL27 signaling are also
required for IEL differentiation in vivo. Analysis of intestinal cells
from naive Ifngr1–/– and Ifngr1+/– littermate and cage-mate
control mice revealed a sharp decrease in the peripheral
TCRab+CD4+CD8aa+ (TL-tetramer+, CD8b–) IELs in mice lack-
ing IFN-gR (Figure 6A and B). Additionally, a significant
decrease in the single-positive TCRab+CD8aa+ (TL-tetramer+,
CD4–CD8b–) IEL population was found in mice lacking IFN-gR
(Figures 6C and 6E). However, we did not observe significant
differences in the frequency of TCRab+CD8b+CD8aa+ (CD4–)
or TCRgd+CD8aa+ (TL-tetramer+, CD4–CD8b–) IEL populations
in Ifngr1–/– mice (Figures 6B–6E). Next, we analyzed intestinal
cells from naive Il27ra–/– and Il27ra+/– littermate and cage-mate
control mice. Contrary to Ifngr1–/– mice, animals lacking IL-
27Ra (WSX-1) were found to have a decreased frequency of
TCRab+CD8b+CD8aa+ and TCRgd+CD8aa+ IELs, but had
intact TCRab+CD4+CD8aa+ and single-positive TCRab+CD8aa+
populations (Figures 6F–6J). Consistent with a T-bet-depen-
dent process, we observed reduced T-bet expression in IEL
populations isolated from either Ifngr1–/– or Il27ra–/– mice (data
not shown). These observations suggest distinct and comple-
mentary roles for IFN-g and IL-27 in the differentiation of several
IEL populations.
In addition to IFN-g and IL-27, RA has also been shown to
induce T-bet expression under conditions of TGF-b exposure
in vitro (Takahashi et al., 2012). Furthermore, we recently showed
that mice conditionally expressing a dominant-negative form ofFigure 4. Runx3 and T-bet Play Both Synergistic and Complementary
(A–D) Sorted naive CD4+GFPhi T cells isolated from WT or Cd4DRunx3 Zbtb7b -G
50 days later. Prior to transfer cells were transduced with Tbx21-expressing or em
gated TCRb+CD4+CD8b– small intestine IELs of recipient mice. (C) RORgt, T-
mesenteric lymph node (mLN) and small intestine IEL compartment of recipient
(E) IL-17 and IFN-g expression by sorted naive CD4+ T cells isolated from T
both (Tbx21+Runx3), or empty control (mock) retroviruses. Transduced cells wer
(TGF-b+IL-6+IL1b+IL-23). Plots are representative of two independent experimethe RA receptor RARa in CD4+ T cells (Cd4[dnRaralsl/lsl mice])
(Rajaii et al., 2008) lack a CD4+CD8aa+ IEL population (Reis
et al., 2013) suggesting an important role for RA signaling in
the induction of the IEL phenotype in gut CD4+ T cells. To directly
assess the contribution of RARa signaling to the induction of T-
bet-dependent CD4-IEL maturation, we crossed OTII mice with
Cd4(dnRaralsl/lsl) mice on a Zbtb7b-GFP background (OTII
[dnRara]). We found reduced T-bet upregulation by OTII (dnRara)
cells upon exposure to TGF-b and RA plus IFN-g conditions
when compared to WT OTII cells (Figure 6K). Consistent with
this finding, TGF-b and RA plus IFN-g enhanced CD8a and
CD103 and suppressed ThPOK expression in WT OTII cells,
but not in cells expressing dnRara (Figures 6L and 6M).
Overall, these results support a feedforward mechanism,
where T-bet-inducing cytokines lead to T-bet-mediated upregu-
lation of Runx3 via39 kb and17 kb regulatory elements, after
which T-bet and Runx3 have complementary roles in the down-
regulation of ThPOK and the induction of the IEL differentiation
program.
DISCUSSION
A single layer of epithelial cells separates the intestinal lumen
from the lamina propria. IELs, which reside at this intersection
between the external environment and the body, therefore
constitute the lymphocyte population most exposed to environ-
mental perturbations. This study provides insights into previ-
ously unknown molecular requirements for IEL maturation. We
showed that a cytokine milieu resembling the gut environment
induces an IEL program in T cells in a T-bet-dependent manner.
This was confirmed by in vivo experiments in mice lacking T-bet,
IL-27Ra, or IFN-gR, which displayed consequent defects in IEL
development. Finally, we described synergistic and complemen-
tary effects of T-bet and Runx3 in this process.
The most pronounced effect of T-bet deficiency was the sharp
decrease in the CD8aa-expressing IEL populations. Indeed,
CD8aa expression represents a common feature of IELs (Cher-
outre and Lambolez, 2008). The so-called ‘‘natural’’ or ‘‘thymic’’
IELs (TCRab+CD8aa+ and TCRgd+CD8aa+) are present at birth
and express several molecules associated with downregulated
antigen reactivity and with anti-inflammatory activity (Cheroutre
et al., 2011; Denning et al., 2007; Gangadharan et al., 2006).
Induced IELs (TCRab+ CD4+CD8aa+ and CD8b+CD8aa+), similar
to induced Treg cells, expand upon antigen encounter in the
periphery (Huang et al., 2011; Mucida et al., 2013). The findings
presented here link T-bet to these two temporally and geograph-
ically distinct IEL differentiation processes. The drastic decrease
in the single-positiveCD8aa+TCRab+ population inTbx21–/–mice
could indicate a role for T-bet during T cell agonist selection in the
thymus (Leishman et al., 2002; Yamagata et al., 2004). It is
possible that T-bet is required for developmental steps inRoles in Functional Differentiation of Intestinal T Cells
FP mice were adoptively transferred to Rag1–/– recipients, and analyzed 40 to
pty control (mock) retrovirus. (A) CD8a, (B) CD103, and ThPOK expression by
bet, and (D) Foxp3 expression by TCRb+CD4+CD8b– cells isolated from the
mice. Plots are representative of two independent experiments.
bx21–/– mice and infected with Tbx21-Thy1.1 (Tbx21), Runx3-GFP (Runx3),
e cultured in vitro for 4.5 days under Th17-polarizing differentiation conditions
nts. Error bars represent SEM.
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Figure 5. Hierarchical Roles for Runx3 and T-bet in IEL Differentiation
(A) Histogram and mean fluorescence index (MFI) of CD103 expression by WT CD4+ T cells transduced with Runx1, Runx3, or an empty retrovirus (mock).
(B) Histogram of Runx3-YFP expression by small intestinal IEL populations from WT or Tbx21–/– (DTbx21) Runx3-YFP reporter mice.
(C) Runx3 expression by sorted small intestinal IEL populations from WT and Tbx21–/– mice.
(D and E) Anti-T-bet ChIP-qPCR for the1 kb region ofUp1, the34 kb CNS region of Ifng, the39 kb and the17 kbRunx3 regulatory regions (D) or the Zbtb7b
RBS 1 and 2 (E) in sorted peripheral CD4+ and CD8+ T cells fromWTmice,Cd4(DRunx3) and Tbx21–/– mice. In (D), the regions39 kb and17 kb of Runx3were
only analyzed in cells from WT and Tbx21–/– mice. Error bars represent SD from pooled independent ChIP-qPCR experiments with biological replicates.
(F and G) Anti-T-bet ChIP-qPCR (as in D and E) in sorted naive Va2+CD4+ T cells isolated fromWTOTII mice cocultured with DCs, OVA peptide, and IL-12 + aIL-
4 (Th1) or TGF-b+RA+IFN-g (CD4CD8aa). Error bars represent SD from pooled independent ChIP-qPCR amplification analysis.
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Role of T-bet in IEL Maturationprecommitted CD4+CD8b+CD8aa+ triple-positive (TP) thymo-
cytes that differentiate toward a CD4–CD8– double-negative
(TCRb+) phenotype before leaving the thymus (Gangadharan
et al., 2006). Alternatively, it is plausible that T-bet participates
in later steps of IEL development when precommitted precursors
arrive in the gut environment and upregulate Runx3, requiring IL-
15 for their terminal differentiation (Gangadharan et al., 2006; Po-
bezinsky et al., 2012). Our data support the latter possibility, ex-
tending the range of T-bet inducers involved in this process to
RA, IFN-g, and IL-27. Additionally, Konkel et al. described an
essential role for TGF-b in the development of single-positive
CD8aa+ IELs (Konkel et al., 2011). Our data suggest that the
cooperation between TGF-b, which suppresses T-bet but in-
duces Runx3 (Shi and Stavnezer, 1998), and a T-bet-inducing
environment, most likely containing RA, IFN-g, and/or IL-27, in
addition to IL-15, is involved in the differentiation of T cells into
IELs. This IEL programing generates an ‘‘activated yet resting’’
state, which involves the expression of the TCR corepressor
CD8aa and several molecules associated with both chronic acti-
vation and limited inflammatory capacity (Denning et al., 2007;
Yamagata et al., 2004).
The significant decrease in the ‘‘induced’’ IEL populations also
corroborates a role for T-bet in peripheral activation of mature
T cells and their differentiation into IELs. We focused most of
our studies on the intestinal process that redirects peripheral
CD4+ T cells toward a CD8-like IEL phenotype (Mucida et al.,
2013; Reis et al., 2013). We addressed how CD4+ T helper activ-
ity is suppressed during CD4-IEL differentiation and defined the
molecular requirements for the induction of the IEL program. We
found that a combination of environmental cues, particularly252 Immunity 41, 244–256, August 21, 2014 ª2014 Elsevier Inc.TGF-b, RA, T-bet-inducing cytokines, and transcriptional regula-
tors, including T-bet and Runx3, can mimic signals from the
gut microenvironment to induce CD4-IEL differentiation, a pro-
cess distinct from T-bet-mediated Th1 differentiation or TGF-
b-mediated Treg induction. Contrary to Treg-mediated control
of inflammatory responses, the pathway addressed by this study
relates to cell-intrinsic control of the inflammatory potential of
T cells. A recent report by Fuchs and coworkers described a
TGF-b-responsive, T-bet-dependent population of innate lym-
phoid cells present in the intraepithelial compartment of the
gut that quickly responds to environmental stimuli by producing
IFN-g (Fuchs et al., 2013). This population also has features of
IELs, and it is tempting to speculate that these cells could be
involved in the tissue-specific, terminal differentiation of T cells
or in their modulation within the epithelial layer. Several cell types
could serve as additional sources of IFN-g in the gut under phys-
iological or pathological conditions, from IELs to lamina propria
NK cells or T cells. Whether T-bet expression by intestinal
T cells oscillates during events that trigger IFN-g and additional
T-bet-inducing cytokines, such as IL-15 and IL-27, and the
consequences of such oscillations remain to be investigated.
Nevertheless, our data indicate a differential requirement for
IFN-gR- or IL-27Ra-mediated signaling by IEL subpopulations.
Likewise, additional studies are needed to dissect the role of
the indigenous microbiota in induction of the IEL phenotype.
Although natural IELs are mostly stable under germ-free condi-
tions, our recent report showing drastic reduction in the induced
CD4+CD8aa+ IEL population in germ-free mice, but recovery
upon microbial reconstitution, points to commensal bacteria as







Figure 6. Retinoic Acid and T-bet-Inducing
Cytokines Play Specific Roles in IEL Differen-
tiation
(A–J) Ex vivo analysis of small intestinal IELs from
12- to 16-week-old Ifngr1–/– mice and Ifngr1+/–
littermate and cagemate controls (A–E) or from 8- to
10-week-old Il27ra –/– mice and Il27ra+/– littermate
and cage mate controls (F–J). (A and F) CD8a and
CD103 expression by gated TCRab+CD4+CD8b–
IELs. (B and G) TL-tetramer (CD8aa) quantification
in induced IELs, TCRab+CD4+CD8b– (left), and
TCRab+CD8b+ (right). (C and H) CD8aa and CD8b
expression by gated TCRb+CD4 IELs. (D and I)
Ratio of TCRgd+ to TCRab+ among CD45+ cells. (E
and J) CD8aa quantification in natural IELs, TCRgd+
(left), and TCRab+CD4–CD8b– (right).
(K–M) Sorted naive Va2+CD4+ T cells isolated from
WT and (OTII) dominant-negative RA receptor (OTII
[dnRara]) Zbtb7b -GFP reporter mice were cocul-
tured with DCs, OVA peptide, and indicated cyto-
kines. (K) Histograms of T-bet expression by OTII
cells from WT (OTII) or (OTII[dnRara]).
(L) CD8b andCD8a expression by CD4+ T cells from
OTII (left) or OTII (dnRara) (right) mice.
(M) Histogram of ThPOK (left) and CD103 (right)
expression by gated CD4+CD8b– OTII cells. Plots
are representative of three independent experi-
ments. Statistical significance analyzed by Stu-
dent’s t test of pooled experiments. Error bars
represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
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Role of T-bet in IEL MaturationTo undergo CD4-IEL differentiation, peripheral CD4+ T cells
lose main features of CD4+ helper cells. We showed that T-bet
suppresses both Th17 and Treg cell-associated genes during
CD4-IEL differentiation, independent of Runx3 expression. Pre-
vious reports have shown analogous suppressive effects of
T-bet during Th2, Th17, and Treg cell differentiation. These func-
tions require T-bet-mediated silencing of respective ‘‘master
regulator’’ transcription factors; i.e., GATA-3 in Th2 cells, RORgt
in Th17 cells and Foxp3 in Treg cells (Djuretic et al., 2007; Koch
et al., 2009; Lazarevic et al., 2011; Zhu et al., 2012). A recent
study described that cooperation between T-bet and Runx
transcription factors is required for IFN-g production by patho-
genic Th17 cells (Wang et al., 2014). Although we did observe
increased frequency of IFN-g-IL-17 double-producing cells in
T-bet deficient animals, these cells did not induce intestinal
inflammation in a murine model of transfer colitis. Further char-
acterization of pathogenic CD4+ T cells in colitis and the role of
T-bet in this process is therefore necessary.
In our studies, T-bet also supported an IEL program in CD4+
T cells by enhancing ThPOK loss and CD8aa expression. These
effects could be direct, through T-bet binding to Zbtb7b regula-
tory elements, or indirect, by binding and modulation of Runx3
expression. Runx3 protein was required for T-bet binding
to Zbtb7b regulatory elements, which implies significance for
T-bet-Runx3 protein-protein interaction, similar to what was
described for Th1 and CD8+ T cell effector differentiation
(Cruz-Guilloty et al., 2009; Djuretic et al., 2007). T-bet is pre-
dicted to bind several other genes related to IELs, including Itgae
(CD103) andCrtam (Nakayamada et al., 2011), although our data
indicate that expression of Runx3 might be required for T-bet-
mediated regulation of these genes, as well. This hypothesis is
also supported by our in vivo analysis of Tbx21 overexpression
in transferred WT versus DRunx3 CD4+ T cells and by the
requirement for TGF-b in CD8aa+ IEL development (Konkel
et al., 2011).
Master regulator transcription factors play defining roles in the
initial differentiation process of all main T cell lineages, including
CD4+ T cell helper and regulatory subsets. This study shows that
cooperation between master regulators might also influence the
late functional maturation of T cells, allowing for plasticity in the
context of different environmental perturbations. In particular,
we uncovered how diverse signals from the highly perturbed in-
testinal mucosa are integrated during intestinal lymphocyte




C57BL/6, OTII TCR transgenic, Rag1–/–, Ifngr1–/–, Il27ra–/–, and Tbx21–/– mice
were purchased from the Jackson Laboratories and maintained in our facil-
ities. Cd4(DRunx3) mice were described previously (Reis et al., 2013). Domi-
nant-negative Raralsl/lsl, Runx3-YFP, and Zbtb7b-GFP reporter mice were
generously provided by R. Noelle (Rajaii et al., 2008), D. Littman, and I. Taniu-
chi, respectively. Several of these lines were interbred in our facilities to
obtain the final strains described in the text. Mice were maintained at
The Rockefeller University animal facilities under specific pathogen-free con-
ditions, and sentinel mice from the Rag1–/– mouse colony were tested to
be negative for Helicobacter spp. and C. rodentium. Mice were used at
7–12 weeks of age for all experiments except when otherwise indicated. An-
imal care and experimentation were consistent with the NIH guidelines and254 Immunity 41, 244–256, August 21, 2014 ª2014 Elsevier Inc.were approved by the Institutional Animal Care and Use Committee at The
Rockefeller University.
In Vitro T Cell Culture
Naive (defined as CD4+CD25–CD62hiCD44lo) T cells were sorted with a FACS
Aria cell sorter (Becton Dickinson) and cultured for 4.5 days in 96-well plates
precoated with 2 mg/ml of anti-CD3ε (17A2) and 1 mg/ml of soluble anti-
CD28 (37.51) with indicated cytokines (all from R&D). OTII cells were cocul-
tured with magnetic bead-isolated (MACS, Miltenyi Biotec) CD11c+ splenic
DCs in the presence of 500 nM OVA peptide and indicated cytokines. For
details, see Supplemental Experimental Procedures.
Retroviral Transduction of CD4+ T Cells
Retroviral vectors forRunx1 andRunx3were previously described (Muroi et al.,
2008; Naoe et al., 2007). Retroviral vectors for T-bet were generously provided
by L. Glimcher (Cornell) and were previously described (Lazarevic et al., 2011).
Transduction of CD4+ T cells with retroviral vectors was performed as previ-
ously described (Muroi et al., 2008; Naoe et al., 2007). For details, see Supple-
mental Experimental Procedures.
Experimental Colitis Model
Colitis was induced after transfer of 5 3 105 sorted naive T cells into Rag1–/–
mice, as previously described (Mucida et al., 2007). Recipient mice weremoni-
tored regularly for signs of disease, including weight loss, hunched appear-
ance, piloerection of the coat, and diarrhea, and analyzed at various times after
the initial transfer or when they reached 80% of their initial weight.
Chromatin Immunoprecipitation qPCR
ChIP was performed as previously described (Setoguchi et al., 2008; Wang
et al., 2014). Briefly, chromatin was prepared from 5–103 106 ex vivo-isolated
cells or from 3 3 106 in vitro differentiated Th1 and CD4+CD8aa+ cells. Cells
were fixed with 1% (vol/vol) methanol-free formaldehyde and lysed. The chro-
matin was sonicated to obtain fragments around 500 bp–1 kb in length and
incubated with Protein A beads coupled to anti-T-bet antibody (H-210) over-
night at 4C. Immunoprecipitated chromatin was treated with Proteinase K
overnight at 56C. DNA was extracted by phenol-chloroform extraction fol-
lowed by ethanol precipitation. Extracted DNA was analyzed by real-time
PCR with different primer sequences. For details, see Supplemental Experi-
mental Procedures.
Statistics
Statistical analysis was performed in GraphPad Prism software. Data were
analyzed by applying one-way ANOVA or unpaired Student’s t test whenever
necessary. A p value of less than 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/10.
1016/j.immuni.2014.06.017.
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